Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (AMEX:RSY)
Historical Stock Chart
From Jul 2019 to Jul 2024
Recom Managed Systems (AMEX:RSY) announced that it has
named Susan Keitt as Director of Recom's Cardiac Services Division and
Alaine Sosebee as Clinical Manager of Cardiac Services. These
appointments complete the division's management team and allow Recom
to immediately implement its plan for a full-service ambulatory
monitoring center, which will begin operations upon introduction of
the company's Model 100 Heart Monitor in settings outside the
physician's office.
"Susan Keitt and Alaine Sosebee collectively bring invaluable
experience in the cardiac-monitoring marketplace to Recom, and we are
pleased to have them on board to administer our monitoring services,"
said Pamela Bunes, president and chief executive officer of Recom.
"Their expertise will complement our ongoing preparations to monitor
electrocardiograph signals from patients using Recom's Model 100 or
the other monitoring products we have developed and those that are
under development."
Ms. Keitt has distinguished herself in the monitoring industry,
most recently as the national director of Holter services for
Lifewatch, a division of Card Guard, Inc. Prior to that, she was the
national director for Monitor Medx Cardiac Monitoring Service Center.
Ms. Keitt also is an expert in complex cardiac-monitoring
reimbursement topics, which will be an asset to Recom. She was
director of reimbursement for MRM Monitoring and a former division
administrator for Tokos Medical, Inc. Ms. Keitt is a graduate of the
University of South Carolina with a degree in business administration.
Ms. Sosebee formerly was the national manager of Holter services
for Lifewatch; prior to that, she served as the clinical manager for
Monitor Medx. She has 17 years of direct clinical experience in
hospital-based cardiac monitoring that will allow Recom to better
identify opportunities to modify its proprietary signal-processing
technology for other applications within the hospital environment.
About Recom Managed Systems, Inc.
Recom Managed Systems, Inc. is an emerging life-sciences company
focused on the monitoring and detection of disease through continuous
biomedical signal monitoring. Recom Managed Systems, Inc. uses its
patented signal technology to design and develop medical devices that
simplify and reduce the costs of diagnostic testing and patient
monitoring in an ambulatory setting. With its patented
signal-technology platform, Recom brings clinical-quality
physiological signal monitoring to the ambulatory setting.
Recom's first product, the Model 100 Heart Monitor, is an
ambulatory patient heart monitor that uses patented signal-processing
technology to record a clinical-quality ECG signal in the presence of
interference generated by the patient's body movements and ambient
environment. The Model 100 has received 510(k) clearance from the Food
and Drug Administration.
Recom Managed Systems, Inc. is traded on the American Stock
Exchange under the symbol RSY. More information is located at
http://www.recom-systems.com
Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are
"forward-looking" statements. Forward-looking statements involve known
and unknown risks, which may cause Recom's actual results in the
future to differ materially from expected results. Factors which could
cause or contribute to such differences include, but are not limited
to, failure to complete the development and introduction of new
products or services, failure to obtain federal or state regulatory
approvals governing medical devices, monitoring and other related
services or products, inability to obtain physician, patient or
insurance acceptance of Recom's products or services, adverse
equity-market conditions and declines in the value of Recom's common
stock, and the unavailability of financing to complete management's
plans and objectives. These risks are qualified in their entirety by
cautionary language and risk factors set forth and to be further
described in Recom's filings with the Securities and Exchange
Commission.